Clinical Trials List
2025-10-01 - 2030-06-30
Recruiting11
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Ta Kao Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
- 洪元 Division of Cardiovascular Diseases
- 陳彥舟 Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JEN-KUANG LEE Division of General Internal Medicine
- YEN-HUNG LIN Division of General Internal Medicine
- 柯宗佑 Division of General Internal Medicine
- 陳盈憲 Division of General Internal Medicine
- 鄭人方 Division of General Internal Medicine
- Tzung-Dau Wang Division of General Internal Medicine
- 林廷澤 Division of General Internal Medicine
- MAO-HSIN LIN Division of General Internal Medicine
- Hsien Li Kao Division of General Internal Medicine
- 黃慶昌 Division of General Internal Medicine
- LIAN-YU LIN Division of General Internal Medicine
- HUNG-JU LIN Division of General Internal Medicine
- 陳俊凱 Division of General Internal Medicine
- Chih-Fan Yeh Division of General Internal Medicine
- 孟士瑋 Division of General Internal Medicine
- 林柏志 Division of General Internal Medicine
- 洪啟盛 Division of General Internal Medicine
- 賀立婷 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文弘 Division of Cardiovascular Diseases
- 藍偉仁 Division of Cardiovascular Diseases
- 宋國慈 Division of Cardiovascular Diseases
- 簡世杰 Division of General Internal Medicine
- 簡楨彥 Division of Cardiovascular Surgery
- 吳書豪 Division of Cardiovascular Diseases
- 蔡佳伶 Division of Cardiovascular Diseases
- 顏志軒 Division of General Internal Medicine
- 陳冠廷 Division of Cardiovascular Diseases
- 蔡憲岳 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柴漢東 Division of Cardiovascular Diseases
- 劉文浩 Division of Cardiovascular Diseases
- 方燕楠 Division of Cardiovascular Diseases
- 鍾文榮 Division of Cardiovascular Diseases
- Huang-Chung Chen Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chern-En Chiang Division of Cardiovascular Diseases
- 李慶威 Division of Cardiovascular Diseases
- 蔡泉財 Division of Cardiovascular Diseases
- 吳承學 Division of Cardiovascular Diseases
- 張皓智 Division of Cardiovascular Diseases
- 蔡依霖 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- 張俊欽 Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂尚謁 Division of General Internal Medicine
- 黃志勤 Division of General Internal Medicine
- Ping-Han Lo Division of General Internal Medicine
- 陳科維 Division of General Internal Medicine
- 謝禮全 Division of General Internal Medicine
- Wei-Chung Wang Division of Neurology
- 陳琦棟 Division of General Internal Medicine
- 魏榮廷 Division of General Internal Medicine
- 鄭英男 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林子傑 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
95 participants
-
Global
11800 participants
